Display options
Cite
Eugene AR, Nicholson WT. The Brain and Propranolol Pharmacokinetics in the Elderly. Brain (Bacau). 2015;6(1):5-14
Eugene, A. R., & Nicholson, W. T. (2015). The Brain and Propranolol Pharmacokinetics in the Elderly. Brain : broad research in artificial intelligence and neuroscience, 6(1), 5-14.
Eugene, Andy R, and Nicholson, Wayne T. "The Brain and Propranolol Pharmacokinetics in the Elderly." Brain : broad research in artificial intelligence and neuroscience vol. 6,1 (2015): 5-14.
Eugene AR, Nicholson WT. The Brain and Propranolol Pharmacokinetics in the Elderly. Brain (Bacau). 2015 Nov;6(1):5-14. PMID: 26609425; PMCID: PMC4655970.
Copy Download .nbib Format: NLM
Share it on

Brain (Bacau). 2015 Nov;6(1):5-14.

The Brain and Propranolol Pharmacokinetics in the Elderly.

Brain : broad research in artificial intelligence and neuroscience

Andy R Eugene, Wayne T Nicholson

Affiliations

  1. Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Gonda 19, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA, Tel.: +1-507-284-2790;
  2. Department of Anesthesiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905.

PMID: 26609425 PMCID: PMC4655970

Abstract

Propranolol, a non-selective β-blocker, has been found to have a tremendous array of indications. Recent evidence has suggested that propranolol may be effective in patients suffering from post-traumatic stress disorder by suppressing activity in the amygdala and thereby inhibiting emotional memory formation. Dosage requirements have been well established in the pediatric and adult population, however, there has been no definitive geriatric dose recommended in the package inserts made available to the public. The aim of this paper is to use pharmacokinetic simulations in order to establish a pharmacokinetic profile dosage equivalent for the elderly as has been found in young patients. After completing the Monte-Carlo simulations for the elderly and young patients, a single 10mg dose in the elderly has shown comparable pharmacokinetic profiles as found in young patients administered a 40mg single dose.

Keywords: brain; elderly; pharmacokinetics; propranolol

References

  1. Bone. 2012 Feb;50(2):490-8 - PubMed
  2. In Vitro Cell Dev Biol. 1989 Apr;25(4):311-20 - PubMed
  3. Hypertension. 1988 Mar;11(3 Pt 2):II21-9 - PubMed
  4. J Trauma Stress. 2007 Dec;20(6):923-32 - PubMed
  5. J Burn Care Res. 2009 Jan-Feb;30(1):92-7 - PubMed
  6. Pediatr Dermatol. 2009 Sep-Oct;26(5):610-4 - PubMed
  7. Psychol Med. 2010 Nov;40(11):1839-48 - PubMed
  8. PLoS One. 2014 Jun 06;9(6):e97885 - PubMed
  9. Circulation. 1975 Nov;52(5):886-93 - PubMed
  10. Br J Pharmacol. 1997 Feb;120(4 Suppl):285-99; discussion 283-4 - PubMed
  11. Biol Psychiatry. 2002 Jan 15;51(2):189-92 - PubMed
  12. Am Fam Physician. 1987 Jul;36(1):112-6 - PubMed
  13. Nature. 1994 Oct 20;371(6499):702-4 - PubMed
  14. Comput Methods Programs Biomed. 2010 Sep;99(3):306-14 - PubMed
  15. Biol Psychiatry. 2012 Feb 15;71(4):380-6 - PubMed
  16. J Clin Psychiatry. 2007 Jun;68(6):929-34 - PubMed
  17. Clin Pharmacokinet. 1976;1(4):233-63 - PubMed
  18. J Neurosci. 2011 Apr 27;31(17):6277-88 - PubMed
  19. Wiad Lek. 2006;59(5-6):388-91 - PubMed
  20. Clin Adv Hematol Oncol. 2007 Mar;5(3):181-2 - PubMed
  21. J Clin Endocrinol Metab. 2012 Nov;97(11):4219-27 - PubMed
  22. Comput Methods Programs Biomed. 2013 May;110(2):203-14 - PubMed
  23. Br J Clin Pharmacol. 1979 Jan;7(1):49-54 - PubMed
  24. Br Med J. 1971 Feb 27;1(5747):490-1 - PubMed
  25. Br J Clin Pharmacol. 1975 Aug;2(4):303-6 - PubMed
  26. Br Med J. 1974 Apr 6;2(5909):14-6 - PubMed
  27. Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11454-8 - PubMed

Publication Types

Grant support